AN ORALLY ACTIVE ALPHA 4 INTEGRIN ANTAGONIST AJM300 PREVENTS THE DEVELOPMENT OF EXPERIMENTAL COLITIS INDUCED BY ADOPTIVE TRANSFER OF IL-10 DEFICIENT CD4+ T CELLS IN MICE.

(1) Pharmaceutical Research Laboratories, AJINOMOTO CO., INC, KAWASAKI, Japan



This item was part of the IMMFLAMMATORY BOWEL DISEASE I session at Gastro 2009 UEGW/WCOG London (17th UEGW)